The New Frontier in Ophthalmic Care
Smartlens is redefining anterior segment disease management through breakthrough technologies for continuous monitoring, diagnosis, and treatment optimization — starting with glaucoma, the leading cause of irreversible blindness worldwide.
- miLens™ — the world's smallest wearable microfluidic contact lens for remote, electronics-free intraocular pressure (IOP) monitoring. In U.S. pivotal trials.
- Smartlens Anterior Segment Platform — AI-powered remote examination for dry eye, cataracts, uveitis, and other anterior segment conditions. In U.S. pivotal trials.
- THERx IQ™ — automated micro-dose medication delivery for chronic eye disease. In pilot trials.
- miLens IQ+™ — AI/ML analytics platform for diurnal IOP and imaging data.
- 🌐 Website: smartlens.health
- 👁️ About: smartlens.health/about
- 👥 Team: smartlens.health/team
- 🔑 Request access: smartlens.health/access
- ✉️ Contact: smartlens.health/contact
- 💼 LinkedIn: @smartlens-health
Building a world where glaucoma and other anterior segment diseases no longer steal vision.